DSC ADVISORS, L.P. – VYNE Therapeutics Inc. Transaction History
DSC ADVISORS, L.P. portfolio value:
$596,000
portfolio value
DSC ADVISORS, L.P. quarter portfolio value change:
-42.63%
quarter
VYNE Therapeutics Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -442K | $0.22 | 2.67M | |
| Q2 2022 | share | 0.00% | 0 shares | -698K | $0.39 | 2.67M | |
| Q1 2022 | share | Increase | +4.66% | 119K shares | -866K | $0.65 | 2.67M |
| Q4 2021 | share | Increase | +131.91% | 1.45M shares | 1.07M | $1.08 | 2.55M |
| Q3 2021 | share | 0.00% | 0 shares | -2.33M | $1.39 | 1.1M | |
| Q2 2021 | share | Increase | +5.96% | 61.85K shares | -3.24M | $3.51 | 1.1M |
| Q1 2021 | share | Increase | 0.00% | 1.03M shares | 7.10M | $6.85 | 1.03M |